News

Filter

Current filters:

tacrolimusImmunologicals

Veloxis Pharma in LCP-Tacro deal with Chiesi

07-10-2012

Denmark's Veloxis Pharmaceuticals A/S (OMX: VELO) has entered into an exclusive distribution agreement…

Chiesi FarmaceuticiEuropeImmunologicalsLCP-TacroLicensingPharmaceuticaltacrolimusVeloxis Pharmaceuticals

Novartis expands transplant portfolio with first branded generic tacrolimus

04-04-2012

Swiss drug major Novartis has announced the US introduction and availability of Hecoria (tacrolimus)…

Astellas PharmaGenericsHecoriaImmunologicalsMarkets & MarketingNorth AmericaNovartisPrografSandoztacrolimus

Substitution of brand name tacrolimus with generic proves safe for transplant recipients

14-09-2011

The substitution of a brand name immunosuppressive drug with a generic (manufactured by Novartis generics…

Astellas PharmaBiotechnologyGenericsImmunologicalsPrografResearchtacrolimus

Panacea Biotec in deal with Uruguay’s Clausen to market Pangraf in Europe

07-03-2011

India’s third-largest biotech firm Panacea Biotec (PNCB: IN) has signed a non-exclusive marketing…

BiotechnologyEuropeImmunologicalsLab ClausenLicensingPanacea BiotecPangrafPharmaceuticalSouth Americatacrolimus

US court rejects Astellas’ appeal on generic immunosuppressants

14-09-2009

The US District Court in Washington DC has denied the Temporary Restraining Order and Preliminary Injunction…

Asia-PacificGenericsImmunologicalsNorth AmericaNovartisNystatinOralPrografProtopicSandoztacrolimus

Astellas Announces the Outcome of its Citizen Petition in the USA

11-08-2009

Japan’s Astellas Pharma says that its North American affiliate has received notice that the US.…

Asia-PacificAstellas PharmaImmunologicalsNorth AmericaNovartisNystatinOralPharmaceuticalPrografProtopicSandoztacrolimus

Back to top